logo

Alterity Therapeutics Limited (ATHE)



Trade ATHE now with
  Date
  Headline
6/23/2021 9:25:43 AM Alterity Therapeutics Receives European Union Regulatory Guidance For ATH434 Phase 2 Trial
2/9/2021 8:56:41 AM Alterity Announces Funding From Michael J. Fox Foundation For ATH434 Dose Optimization
1/7/2021 8:19:50 AM Alterity Therapeutics Appoints David Stamler As CEO
1/5/2018 1:20:37 PM B. Riley FBR Starts Prana Biotechnology Ltd (PRAN) At Buy With $4.00 Price Target